|
|
|
|
|
|
|
Halozyme Therapeutics Inc. (HALO)
|
|
15.69 0.01 (0.06%)
|
10-23 14:04
|
|
Open:
|
15.4
|
Pre. Close:
|
15.68
|
|
High:
|
15.85
|
Low:
|
15.04
|
|
Volume:
|
526,962
|
Market Cap:
|
2252M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
16.535 - 16.65
|
16.65 - 16.739
|
|
Low:
|
15.082 - 15.231
|
15.231 - 15.346
|
|
Close:
|
15.471 - 15.676
|
15.676 - 15.833
|
|
|
|
Technical analysis (as of: 2018-10-23 1:43:26 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, upgraded from strong sell. But this stock still is very strong for short side. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.
|
|
Target:
|
Six months: 20.25  One year: 21.91
|
|
Support:
|
Support1: 15.04 Support2: 12.51
|
|
Resistance:
|
Resistance1:
17.34 Resistance2: 18.76
|
|
Pivot:
|
17.35
|
|
Moving Averages:
|
MA(5): 16.67 MA(20): 17.55
MA(100): 17.70 MA(250): 18.54
|
|
MACD:
|
MACD(12,26):
-0.36 Signal(12,26,9): -0.13
|
|
%K %D:
|
%K(14,3): 10.27 %D(3): 22.29
|
|
RSI:
|
RSI(14): 33.77
|
|
52-Week:
|
High: 21.48
Low: 15.04 Change(%): -6.2
|
|
Average Vol(K):
|
3-Month: 87635
10-Days 92563
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.HALO has closed above bottom band by 4.8%. Bollinger Bands are 92.8% wider than normal. The large width of the bands suggest high volatility as compared to HALO's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
2018-10-22T08:00:00-04:00
Halozyme Provides Summary Results Of Data For PEGPH20 Combination Treatments Presented At ESMO 2018 Congress
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
